HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma.

Abstract
Intermediate filaments are important in building the cellular architecture. Previously we found cytokeratin18 was modulated in human hepatocellular carcinoma. Plectin is a cross-linking protein that organizes the cytoskeleton into a stable meshwork, which can maintain the uniform size and shape of hepatocytes. Because the cells of hepatocellular carcinoma were morphologically different from the hepatocytes, we speculated that expression of plectin and organization of intermediate filament might play roles in the pleomorphism of hepatocellular carcinoma cells. In this paper, we studied the plectin expression of hepatocellular carcinoma and liver tissues by immunohistochemistry and immunoblot. The results revealed that plectin was deficient and cytokeratin18 was modulated in hepatocellular carcinoma. Furthermore, we knockdown the plectin mRNA in Chang cells, the result revealed the plectin was deficient and the organization of cytokeratin18 was altered. Conclusively, this study offers a hypothesis that plectin deficient might play an important role in the tumorigenesis of hepatocellular carcinoma.
AuthorsChiung-Chi Cheng, Yi-Hsiang Liu, Chin-Chin Ho, Wei-Ting Chao, Ren-Jeng Pei, Yung-Hsiang Hsu, Kun-Tu Yeh, Lu-Chang Ho, Ming-Chuang Tsai, Yih-Shyong Lai
JournalJournal of molecular histology (J Mol Histol) Vol. 39 Issue 2 Pg. 209-16 (Apr 2008) ISSN: 1567-2379 [Print] Netherlands
PMID18038249 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Keratin-18
  • Plectin
Topics
  • Carcinoma, Hepatocellular (metabolism, ultrastructure)
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Keratin-18 (metabolism, ultrastructure)
  • Liver Neoplasms (metabolism, ultrastructure)
  • Plectin (antagonists & inhibitors, deficiency, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: